340B Program Controls: House Committee Launches Investigation
Executive Summary
Energy and Commerce Committee leadership requests audit records and other documents from the Health Resources and Services Administration to evaluate the effectiveness of its oversight of the program.
You may also be interested in...
340B Squeeze Begins: New HRSA Head Doesn’t Tip His Hand
HRSA Administrator George Sigounas made his public debut during the annual 340B coalition summer conference in Washington, DC. The setting was significant giving the prominence of the drug discount program on the Trump Administration agenda, but Sigounas didn’t offer much insight into the potential changes to come.
Drug Pricing Reform In US: It’s Over For 2017
There's lots of buzz about drug pricing actions, be they executive or legislative. But the die is cast for this year: real reforms will have to wait.
HHS Action On Drug Pricing: Here's Who Secretary Price Is Listening To
HHS is expected to move ahead with action to address high drug prices following a series of stakeholder roundtables held over the past month.